WallStSmart

Boston Scientific Corp (BSX)vsWheaton Precious Metals Corp (WPM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Boston Scientific Corp generates 767% more annual revenue ($20.07B vs $2.31B). WPM leads profitability with a 63.6% profit margin vs 14.4%. WPM appears more attractively valued with a PEG of 0.43. WPM earns a higher WallStSmart Score of 76/100 (B+).

BSX

Buy

63

out of 100

Grade: C+

Growth: 8.0Profit: 6.5Value: 8.7Quality: 5.5
Piotroski: 4/9

WPM

Strong Buy

76

out of 100

Grade: B+

Growth: 8.7Profit: 9.0Value: 8.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BSXUndervalued (+1.2%)

Margin of Safety

+1.2%

Fair Value

$70.62

Current Price

$69.78

$0.84 discount

UndervaluedFair: $70.62Overvalued
WPMUndervalued (+1.4%)

Margin of Safety

+1.4%

Fair Value

$151.16

Current Price

$122.64

$28.52 discount

UndervaluedFair: $151.16Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BSX4 strengths · Avg: 8.3/10
Market CapQuality
$101.28B9/10

Large-cap with strong market position

PEG RatioValuation
0.758/10

Growing faster than its price suggests

Revenue GrowthGrowth
15.9%8/10

15.9% revenue growth

Free Cash FlowQuality
$1.01B8/10

Generating 1.0B in free cash flow

WPM5 strengths · Avg: 9.8/10
PEG RatioValuation
0.4310/10

Growing faster than its price suggests

Profit MarginProfitability
63.6%10/10

Keeps 64 of every $100 in revenue as profit

Operating MarginProfitability
75.2%10/10

Strong operational efficiency at 75.2%

Revenue GrowthGrowth
127.2%10/10

Revenue surging 127.2% year-over-year

Market CapQuality
$54.92B9/10

Large-cap with strong market position

Areas to Watch

BSX1 concerns · Avg: 4.0/10
P/E RatioValuation
35.1x4/10

Premium valuation, high expectations priced in

WPM1 concerns · Avg: 4.0/10
P/E RatioValuation
37.3x4/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : BSX

The strongest argument for BSX centers on Market Cap, PEG Ratio, Revenue Growth. Revenue growth of 15.9% demonstrates continued momentum. PEG of 0.75 suggests the stock is reasonably priced for its growth.

Bull Case : WPM

The strongest argument for WPM centers on PEG Ratio, Profit Margin, Operating Margin. Profitability is solid with margins at 63.6% and operating margin at 75.2%. Revenue growth of 127.2% demonstrates continued momentum.

Bear Case : BSX

The primary concerns for BSX are P/E Ratio.

Bear Case : WPM

The primary concerns for WPM are P/E Ratio.

Key Dynamics to Monitor

WPM carries more volatility with a beta of 1.11 — expect wider price swings.

WPM is growing revenue faster at 127.2% — sustainability is the question.

BSX generates stronger free cash flow (1.0B), providing more financial flexibility.

Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

WPM scores higher overall (76/100 vs 63/100), backed by strong 63.6% margins and 127.2% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Boston Scientific Corp

HEALTHCARE · MEDICAL DEVICES · USA

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Wheaton Precious Metals Corp

BASIC MATERIALS · GOLD · USA

Wheaton Precious Metals Corp. The company is headquartered in Vancouver, Canada.

Want to dig deeper into these stocks?